aDepartment of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, Netherlands bDepartment of Medical Oncology, Erasmus University Medical Centre, Rotterdam, Netherlands ...

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

New study reports protective effect among people with type 2 diabetes Kidney stones and the systemic conditions associated with them have a major impact on health and the economy in the US and ...

The study is evaluating AJ1-11095, a novel agent for the treatment of myelofibrosis that did not respond to or relapsed ...

New studies to be presented at the American Heart Association meeting focus on disparities in Wegovy prescriptions and ...

This new agent, like the other DPP-4 inhibitors, has a mechanism of action that affects both pancreatic ß-cell survival as well as ß-cell secretory function. These medications do not incite ...

Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...

jpaget.nhs.uk BACKGROUND Interleukin 1β (IL-1β) is a potent inhibitor of gastric acid secretion. Regulatory actions at several levels have previously been demonstrated, including direct inhibition of ...

The inhibitors bind to the catalytic zinc ion within the enzyme cavity. Several such derivatives are clinically used inhibitors, such as acetazolamide, methazolamide, ethoxzolamide ...